Clinical excellence from design to delivery
Take your asset from first-in-human to proof-of-concept in under one year with Richmond Pharmacology. Our long-term partnerships with our international sponsors have led to the completion of over 500 early phase studies.
We have helped to deliver 30 medicines to market.
Our founders are influential clinical experts who actively lead each study. Alongside our team of senior drug development experts, they create adaptive and integrated protocols – enabling faster decision making and reducing drug development timelines.
Together we ensure the quality, integrity, and accuracy of your trial.
We are a full service CRO
Delivering all our specialist services at our purpose-built hospital-style facility in London, next to Guy’s Hospital. As our patient offering expands, so do our facilities. We have dedicated patient wards meeting the highest patient safety standards and ensuring our participants have a comfortable stay.
We're MHRA accredited
We are an MHRA accredited Phase I unit. Our trials adhere to the highest clinical, ethical and safety standards.
We exceed the basic regulatory GCP standards to ensure the patients in our First-In-Human studies are safe, comfortable, and confident in our abilities to handle medical emergencies.
The clinical unit is in the heart of London with easy access to mainline train stations and airports, making it the ideal location to attract research volunteers.
Richmond Pharmacology’s volunteer database houses individuals from a broad demographic spectrum and a wide variety of patient populations across common to rare diseases. The database grows by 1000 to 2000 volunteers each month with a typical 70/30 split between healthy volunteers and patients.